About This Study
Inclusion body myositis (IBM) is an inflammatory autoimmune disorder of skeletal muscle. With IBM harmful immune cells attack muscle causing muscle weakness. The study drug ABC008 has been designed to reduce the number of these harmful immune cells. The purpose of this study is to find out how well the study drug works for treating IBM.
Need volunteers diagnosed with inclusion body myositis. Taking part in this study will involve 17 visits and last about 76 weeks. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 40 - 100 years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Winston-Salem NC